Full name
AMS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
AMS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. WIERZBOWA 21 / 35, 15-743 BIAŁYSTOK
TAX ID5423228836
Rate company:
AMS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5423228836
KRS0000441928
Share capital30,000.00 zł
address
UL. WIERZBOWA 21 / 35, 15-743 BIAŁYSTOK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5423228836
REGON
200746816
KRS
0000441928
Legal form
limited liability company
Register Address
UL. WIERZBOWA 21 / 35, 15-743 BIAŁYSTOK
Date of registration in KRS
2012-11-28
Date of commencement of economic activity
2012-11-28
Act signature
BI.XII NS-REJ.KRS/7439/19/501/ADE
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
10 - Manufacture of food products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.3 - Wholesale trade of food, beverages, and tobacco products
47.2 - Retail trade of food, beverages, and tobacco products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0 | -0,2 | 0 | 110,1 |
EBITDA | 0 | -0,2 | 0 | 117 |
Short time liabilities | 0,3 | 0,3 | 0,3 | -3,1 |
Equity capital | 0,2 | 0 | 0 | 116,1 |
Operating profit (EBIT) | 0 | -0,2 | 0 | 114,9 |
Assets | 0,6 | 0,4 | 0,3 | -14,1 |
Net profit (loss) | 0 | -0,2 | 0 | 110,1 |
Cash | 0 | 0 | 0 | -4,2 |
Net income from sale | 1,2 | 1,3 | 1,3 | 2,5 |
Liabilities and provisions for liabilities | 0,4 | 0,3 | 0,3 | -20 |
Working assets | 0,6 | 0,4 | 0,3 | -13,8 |
Depreciation | 0 | 0 | 0 | 33,3 |
% | % | % | p.p. | |
Profitability of capital | 13 | -1149,6 | 53,7 | 1203,3 |
Equity capital to total assets | 35,1 | 4,4 | 11 | 6,6 |
Gross profit margin | 2,5 | -14,5 | 1,4 | 15,9 |
EBITDA Margin | 3,7 | -13,5 | 2,2 | 15,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 96 | 74 | 70 | -4 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
CYTOGEN-POLSKA
ŁÓDŹ
HS Medical Poland
Tychy
APTEKA ŚW. TOMASZA G. STOWSKA
Katowice
Przedsiębiorstwo Trans-Med
Zawiercie
Katarzyna Poleszak
Toruń
Red Med Poland Sp. z o.o.
Chorzów
DKR Medical sp. z o.o.
Poznań
TBK MEDICAL PARTNER
ŻYWIEC
ZIELARNIA ANNA RADOŃ
Bełchatów